SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : ICN Pharmaceuticals -- Ignore unavailable to you. Want to Upgrade?


To: Clouseau who wrote (952)12/14/1998 11:44:00 PM
From: Ibnbatutaa  Read Replies (2) | Respond to of 1029
 
Re: Rebetron combo for Hep C: for Naive patient use this has blockbuster potential. What is ICN's cut per 48 wk treatment course?
Please see: Message 6836349

Ibn'aa